BITCH BALM Trademark

Trademark Overview


On Sunday, August 4, 2024, a trademark application was filed for BITCH BALM with the United States Patent and Trademark Office. The USPTO has given the BITCH BALM trademark a serial number of 98681839. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, February 24, 2025. The BITCH BALM trademark is filed in the Pharmaceutical Products category with the following description:

Anti-inflammatory salves
bitch balm

General Information


Serial Number98681839
Word MarkBITCH BALM
Filing DateSunday, August 4, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, February 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAnti-inflammatory salves

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, August 4, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressAustin, TX 78748

Trademark Events


Event DateEvent Description
Sunday, August 4, 2024NEW APPLICATION ENTERED
Wednesday, February 19, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 20, 2025ASSIGNED TO EXAMINER
Monday, February 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 24, 2025NON-FINAL ACTION WRITTEN
Monday, February 24, 2025NON-FINAL ACTION E-MAILED

Related Keywords


balm bitch salves inflammatory anti